isocarboxazid has been researched along with Brain Ischemia in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The neuroleptic malignant syndrome is a rare but dangerous complication of treatment with neuroleptics." | 1.28 | Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology. ( Dawson, A; Jones, EM, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, EM | 1 |
| Dawson, A | 1 |
1 other study available for isocarboxazid and Brain Ischemia
| Article | Year |
|---|---|
Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.
Topics: Aged; Brain; Brain Ischemia; Chlorpromazine; Depressive Disorder; Drug Therapy, Combination; Female; | 1989 |